-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Researchers are using the same technology used by the coronavirus vaccine to repair damaged hearts to create the world's first drug to treat heart disease patients
On April 19, the British "Times" website published an article entitled "Coronavirus vaccine technology may bring the first mRNA drug for heart disease"
Scientists at King's College London have discovered the key genetic code - messenger ribonucleic acid (mRNA), which produces a protein that promotes the production of healthy new heart cells, according to reports
In the UK, around 100,000 people are hospitalised with a heart attack each year
So far, the revolutionary approach has been successfully used to regenerate damaged pig hearts, and human trials will begin within two years
Professor Moro Yaka, who led the study, said: "We have a fixed number of muscle cells in the heart from birth and when we die, these cells remain the same
He said: "Using the exact same technology as the Pfizer and Moderna vaccines, we inject microRNA into the heart to make the surviving heart cells proliferate
The team at the Heart Foundation Centre of Excellence at King's College London is also developing a treatment to prevent cells from dying during a heart attack
"If the clinical trial goes well, this will be a blockbuster in the history of heart disease," Yaka said
